Riggs Rory B's Form 4 filing
Intra-Cellular Therapies, Inc. (ITCI) · filed Jun 25, 2024
- Accession no.
- 0000950170-24-077468
- Filed
- Jun 25, 2024
- Trade date
- Jun 23-24, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $337.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Riggs Rory BCIK 0001016835 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2024 | Common Stock | MOption exerciseAcquired | +1,567 | – | – | 101,062 | Direct | |
| Jun 24, 2024 | Common Stock | MOption exerciseAcquired | +20,000 | $16.86 | +$337,200 | 121,062 | Direct | |
| Jun 24, 2024 | Common Stock | SSaleDisposed | −4,462 | $75.57 | −$337,193.34 | 116,600 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2024 | Common Stock | MOption exerciseDisposed | −1,567 | $0.00 | $0 | 0 | Direct | |
| Jun 24, 2024 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.